You are here

Главная страница › COVID-19 patients who could benefit from Paxlovid find price shock › COVID-19 patients who could benefit from Paxlovid find price shock

COVID-19 patients who could benefit from Paxlovid find price shock

Primary tabs

COVID-19 patients who could benefit from Paxlovid find price shock

Mon, 2024-03-11 11:26 — mike kraft
COVID-19 patients who could most benefit from Paxlovid still aren’t getting it - UPI.com Sticker shock has stunned thousands of Americans sick with COVID-19 since late December, as Pfizer shifted to commercial sales of Paxlovid. Before then, the federal government covered the cost of the drug. UPI

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Public Health
Economics
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Группа с ограниченным доступом -
Workflow history
Revision ID Название поля Date Old state New state name By Comment Действия
No state No state
howdy folks
Page loaded in 0.440 seconds.